Reproductive health service provider Marie Stopes International has announced it will begin providing medical abortions using cancer drug methotrexate at clinics in New South Wales, Queensland, Western Australia and Victoria. The move to broaden the offering of medical abortions using methotrexate in combination with another drug, misoprostol, may add momentum to push the more effective abortion pill, RU486, onto the market.